HUYA Bioscience and Wuhan Biolake Form Alliance

The alliance is expected to combine both parties' resources to accelerate the development of pharmaceutical discoveries from China.

HUYA Bioscience International, with focus on globalizing China's pharmaceutical innovations, announced its alliance with Wuhan National Bio-industry Base, also known as Biolake.  The collaboration will combine both parties' resources to accelerate the development of pharmaceutical discoveries from China.

HUYA is one of the first companies to have recognized China's potential to help meet the global need for new preclinical and clinical stage compounds. HUYA has established a series of collaborations with leading universities and research institutions throughout China and has pioneered in-licensing clinical s